Bio

Dr. Rebecca Wu is a Clinical Assistant Professor in the Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, at Stanford Health Care Tri-Valley. She completed her medical education at Boston University School of Medicine followed by an internship at Steward Carney Hospital in Dorchester, MA. She went on to complete her residency training in Diagnostic Radiology at NYU Langone Hospital – Long Island in Mineola, NY, followed by a fellowship year in Nuclear Medicine at UCSF Medical Center. Dr. Wu is board-certified in both Diagnostic Radiology and Nuclear Medicine. Her clinical interests include oncologic imaging and its contributions to multidisciplinary cancer care, radionuclide therapies, and community medicine.

Clinical Focus

  • Nuclear Radiology
  • Positron-Emission Tomography and Computed Tomography
  • SPECT and SPECT/CT
  • Cardiac SPECT Imaging
  • Targeted Radionuclide Therapy
  • Theragnostics

Academic Appointments

Professional Education

  • Board Certification, American Board of Nuclear Medicine, Nuclear Medicine (2016)
  • Board Certification: American Board of Radiology, Diagnostic Radiology (2015)
  • Fellowship: UCSF Nuclear Medicine Fellowship (2015) CA
  • Residency: NYU Grossman Long Island Radiology Residency (2014) NY
  • Internship: Steward Carney Hospital (2010) MA
  • Medical Education: Boston University School of Medicine (2009) MA

Contact

  • Academic
    rewu@stanford.edu
    University - Academic staff Department: Rad/Nuclear Medicine Position: Clinical Assistant Professor
  • Clinical (Primary)  Stanford Health Care Tri-Valley 5555 W Las Positas Blvd Pleasanton, CA 94588 (650) 498-5047 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5281

All Publications

  • Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving <SUP>131</SUP>I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma PEDIATRIC BLOOD & CANCER Lee, J. S., Wu, R., Wong, T., DuBois, S. G., Matthay, K., Gustafson, C., Hawkins, R., Roy-Burman, A. 2016; 63 (3): 471-478

    Abstract

    (131) I-MIBG is increasingly used for treating neuroblastoma; however, administration requires careful adherence to radiation safety guidelines. We describe our experience using continuous sedation to facilitate safe (131) I-MIBG therapy for young children.Patients were included in this case series if they received continuous midazolam or dexmedetomidine infusion for sedation during (131) I-MIBG therapy from November 1, 2012, to October 1, 2014. Key outcomes included adequacy of sedation for both (131) I-MIBG infusion and the duration of radioactive isolation, as well as sedative-related toxicities. Additionally, nuclear medicine scans before and after (131) I-MIBG therapy were assessed using the Curie score. These scores were compared qualitatively between midazolam, dexmedetomidine, and control (no sedative infusion) groups.Of the 13 patients receiving continuous sedation for (131) I-MIBG therapy, seven achieved adequate sedation with midazolam, five achieved adequate sedation with dexmedetomidine, one patient (1.6 years old) failed to achieve adequate sedation with either medication and did not receive (131) I-MIBG therapy. Sedation was generally well tolerated. Common side effects for dexmedetomidine infusion included hypotension and relative bradycardia. Both treatment and control groups had multiple patients with increased Curie scores post-(131) I-MIBG therapy. However, one patient in the midazolam group and two in the dexmedetomidine group had decreased Curie scores after (131) I-MIBG therapy, while none decreased in the control group.Although we cannot exclude the possibility of some inhibition of (131) I-MIBG uptake by midazolam or dexmedetomidine, this case series suggests that continuous infusions of either agent can provide effective sedation to allow safe administration of (131) I-MIBG to young patients.

    View details for DOI 10.1002/pbc.25827

    View details for Web of Science ID 000370247900013

    View details for PubMedID 26585842

  • Image-Guided Percutaneous Cervical Spine Biopsies: A Review of Techniques, Results, and Complication Avoidance Neurographics Wu, R., Tseng, Y., Drexler, S., Ortiz, O. 2014; 4 (2): 8

    View details for DOI 10.3174/ng.2140077

  • Magnetic resonance imaging as an adjunct to ultrasound in evaluating cesarean scar ectopic pregnancy. Journal of clinical imaging science Wu, R., Klein, M. A., Mahboob, S., Gupta, M., Katz, D. S. 2013; 3: 16

    Abstract

    Cesarean scar pregnancies (CSPs) are a relatively rare form of ectopic pregnancy in which the embryo is implanted within the fibrous scar of a previous cesarean section. A greater number of cases of CSPs are currently being reported as the rates of cesarean section are increasing globally and as detection of scar pregnancy has improved with use of transvaginal ultrasound (TVUS) with color Doppler imaging. Delayed diagnosis and management of this potentially life-threatening condition may result in complications, predominantly uterine rupture and hemorrhage with significant potential maternal morbidity. Diagnosis of a cesarean scar pregnancy (CSP) requires a high index of clinical suspicion, as up to 40% of patients may be asymptomatic. TVUS has a reported sensitivity of 84.6% and has become the imaging examination of choice for diagnosis of a CSP. Magnetic resonance imaging (MRI) has been used in a small number of patients as an adjunct to TVUS. In the present report, MRI is highlighted as a problem-solving tool capable of more precisely identifying the relationship of a CSP to adjacent structures, thereby providing additional information critical to directing appropriate patient management and therapy.

    View details for DOI 10.4103/2156-7514.109758

    View details for PubMedID 23814688

    View details for PubMedCentralID PMC3692029

  • Spine and Spinal Cord Anatomy for Tumor Surgery Spine and Spinal Cord Tumors: Advanced Management and Operative Techniques Wu, R., Chen, B., Ortiz, O. CRC Press. 2013; 1st